EMEA-000828-PIP06-18

Key facts

Invented name
Jardiance
Active substance
empagliflozin
Therapeutic area
Uro-nephrology
Decision number
P/0082/2019
PIP number
EMEA-000828-PIP06-18
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of chronic kidney disease
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271
E-mail: paediatrics@boehringer-ingelheim.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating